Status:
UNKNOWN
Colorectal Liver Metastases: Novel Assessment Tools for Technical Resectability
Lead Sponsor:
University of Manchester
Collaborating Sponsors:
Manchester University NHS Foundation Trust
Perspectum
Conditions:
Cancer
Cancer Metastatic
Eligibility:
All Genders
16+ years
Brief Summary
The CoNoR study aims to assess whether the use of the LiMAx test and the HepaT1ca pre-operative planning magnetic resonance scan impact upon technical resectability decision-making in colorectal liver...
Detailed Description
The CoNoR Study will occur via 4 workstreams: 1. Systematic review of all published criteria for colorectal liver metastases (CLM) technical resectability (systematic review protocol published on PRO...
Eligibility Criteria
Inclusion
- Patients over 16 years of age with histologically verified adenocarcinoma of the colon or rectum and radiological evidence of liver metastases
- Discussion at regional hepatobiliary multidisciplinary team meeting
- Hepatobiliary surgical opinion that their case represents a potentially difficult decision regarding technical resectability
- Ability to provide written informed consent
Exclusion
- Presence of a medical or psychiatric condition impairing the ability to give informed consent
- Presence of any other serious uncontrolled medical condition
- Patients under 16 years old
- Contra-indications to magnetic resonance scanning
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04270851
Start Date
April 1 2020
End Date
March 1 2021
Last Update
February 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Christie NHS Foundation Trust
Manchester, Greater Manchester, United Kingdom, M20 4NX